Lymphoma, Large-cell - 16 Studies Found
Terminated |
: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma :
|
Completed |
: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery :
|
Completed |
: RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors :
|
Terminated |
: PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma : Lymphoma, Large-Cell, Diffuse : 2007-08-01 : Drug: PTK787 PTK787 - 1250mg p.o. daily. Initial dose of 750mg p.o daily starting on day 1 and increased |
Completed |
: Large Cell Lymphoma Pilot Study III :
: 2005-09-12 :
|
Completed |
: Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas :
|